Research Articles Library

Search tips: Keywords PMID Journal DOI or use Advanced Search for precise filtering
Literature Analysis Tools
Advanced Search

Filter by PMID, year, source, DOI and other criteria

Literature Analysis

Analyze research trends and hotspots

Batch Export

Export search results to Excel/PDF

Notoginsenoside R1 promotes Lgr5(+) stem cell and epithelium renovation in colitis mice via activating Wnt/β-Catenin signaling

Publication Year: 2024 Source: Acta Pharmacol Sin PMID: 38491161 DOI: 10.1038/s41401-024-01250-7

Inflammatory bowel disease (IBD) is characterized by persistent damage to the intestinal barrier and excessive inflammation, leading to increased intestinal permeability. Current treatments of IBD primarily address inflammation, neglecting epithelial repair. Our previous study has reported the therapeutic potential of notoginsenoside R1 (NGR1), a characteristic saponin from the root of …

Does Combined Medical and Surgical Treatment Improve Perianal Fistula Outcomes in Patients With Crohn's Disease? A Systematic Review and Meta-Analysis

Publication Year: 2024 Source: J Crohns Colitis PMID: 38491943

No Abstract

JPEN Journal Club 83. Selecting trials to include in a systematic review

Publication Year: 2024 Source: JPEN J Parenter Enteral Nutr PMID: 38491963

No Abstract

Change in systemic steroid use and surgery rate in patients with inflammatory bowel disease: a Japanese real-world database analysis

Publication Year: 2024 Source: J Gastroenterol PMID: 38492011 DOI: 10.1007/s00535-024-02086-y

BACKGROUND: Corticosteroids are recommended only for induction of remission in inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn's disease (CD). This study aimed to evaluate the change in pharmacologic treatment use, particularly systemic corticosteroids, over approximately 30 years, and the impact of biologics on IBD treatment since their …

Resveratrol ameliorates DSS-induced ulcerative colitis by acting on mouse gut microbiota

Publication Year: 2024 Source: Inflammopharmacology PMID: 38492181

No Abstract

Tonic TCR and IL-1β signaling mediate phenotypic alterations of naive CD4(+) T cells

Publication Year: 2024 Source: Cell Rep PMID: 38492221

No Abstract

Protective effect of carbon dots as antioxidants on intestinal inflammation by regulating oxidative stress and gut microbiota in nematodes and mouse models

Publication Year: 2024 Source: Int Immunopharmacol PMID: 38492339 DOI: 10.1016/j.intimp.2024.111871

Inflammatory bowel disease (IBD) is a recurrent chronic colitis disease with increasing incidence and prevalence year by year. The single efficacy and significant side effects of traditional IBD treatment drugs have promoted the flourishing development of new drugs. Inspired by many health benefits of carbon dots (CDs) based nanomedicine in …

Exploration of gut microbiome and inflammation: A review on key signalling pathways

Publication Year: 2024 Source: Cell Signal PMID: 38492625

No Abstract

A hairy pedunculated polypoid lesion of sigmoid colon in a woman with abdominal pain and diarrhea

Publication Year: 2024 Source: Gastrointest Endosc PMID: 38492816

No Abstract

Upadacitinib Reduces Crohn's Disease Symptoms Within the First Week of Induction Therapy

Publication Year: 2024 Source: Clin Gastroenterol Hepatol PMID: 38492903

No Abstract

98453 Results
Page of
9846 Pages
Need more literature?

The current database contains 98453 research articles. If you need to search for more literature or perform AI analysis, please use our knowledge acquisition module or explore external literature resources.

Knowledge Acquisition Module: Upload and analyze your own literature files
External Resources: Access comprehensive literature databases worldwide